The Microbiotics Company
BELANO medical AG will team up with b.value AG,
headquartered in Düsseldorf, and Deutsche Biotech Innovativ AG (DBI), which is based in
Hennigsdorf bei Berlin, in the future development and distribution of microbiological and
microbial ingredients for medical products and microbiome products. As part of this
agreement, both companies have acquired shares in BELANO medical.
New microbiotic agent also prevents super-infections
Hennigsdorf b. Berlin, 29 July 2020 – “salvans® throat pastilles”, the world’s first microbiotic
antibacterial lozenges, will be available for sale from 1 August. Intended for use against
bacterial throat infections and inflammations of the pharynx, as well as the prevention of
secondary infections, this medical product contains the microbiotic agent salvans® and
marshmallow root extract.
- BELANO medical Boosts Distribution of Microbiome Products 16. September 2020
- Antibiotics-Free Relief for Strep Throat Infections 31. July 2020